Home
ANIP
ANIP News

Latest ANI Pharmaceuticals Inc. (ANIP) News on January 18, 2025

Is ANI Pharmaceuticals (ANIP) a Great Value Stock Right Now?

Zacks

3 days ago

Is ANI Pharmaceuticals (ANIP) a Great Value Stock Right Now?

Argus Research

4 days ago

ANIP: What does Argus have to say about ANIP?

Alcami Announces CEO Transition

PR Newswire

5 days ago

Alcami Announces CEO Transition

MT Newswires

5 days ago

Ani Pharmaceuticals Sees Fiscal 2024 Adjusted EPS, Revenue at or Above Guidance; Sets Fiscal 2025 Revenue Outlook

ANI Pharmaceuticals Provides Preliminary Fourth Quarter and 2024 Financial Results and Preliminary 2025 Outlook

GlobeNewswire

5 days ago

ANI Pharmaceuticals Provides Preliminary Fourth Quarter and 2024 Financial Results and Preliminary 2025 Outlook

MT Newswires

16 days ago

Sector Update: Health Care Stocks Edge Higher Premarket Thursday

MT Newswires

16 days ago

ANI Pharmaceuticals Launches Generic Version of Motegrity

ANI Pharmaceuticals Announces the FDA Approval and Launch of Prucalopride Tablets with 180-Day CGT Exclusivity

GlobeNewswire

16 days ago

ANI Pharmaceuticals Announces the FDA Approval and Launch of Prucalopride Tablets with 180-Day CGT Exclusivity

Is ANI Pharmaceuticals (ANIP) Outperforming Other Medical Stocks This Year?

Zacks

17 days ago

Is ANI Pharmaceuticals (ANIP) Outperforming Other Medical Stocks This Year?

ANI Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference

GlobeNewswire

19 days ago

ANI Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference

All You Need to Know About ANI (ANIP) Rating Upgrade to Buy

Zacks

23 days ago

All You Need to Know About ANI (ANIP) Rating Upgrade to Buy

Argus Research

a month ago

ANIP: Lowering target price to $57.00

MT Newswires

a month ago

Ani Pharmaceuticals Insider Sold Shares Worth $418,425, According to a Recent SEC Filing

Should Value Investors Buy ANI Pharmaceuticals (ANIP) Stock?

Zacks

a month ago

Should Value Investors Buy ANI Pharmaceuticals (ANIP) Stock?

Argus Research

a month ago

ANIP: Lowering target price to $59.00

MT Newswires

a month ago

Leerink Partners Initiates ANI Pharmaceuticals at Outperform With $80 Price Target

Argus Research

a month ago

ANIP: Raising target price to $62.00

Are Medical Stocks Lagging Adagene (ADAG) This Year?

Zacks

a month ago

Are Medical Stocks Lagging Adagene (ADAG) This Year?

Argus Research

a month ago

ANIP: Lowering target price to $60.00

Should Value Investors Buy ANI Pharmaceuticals (ANIP) Stock?

Zacks

2 months ago

Should Value Investors Buy ANI Pharmaceuticals (ANIP) Stock?

MT Newswires

2 months ago

Ani Pharmaceuticals Insider Sold Shares Worth $1,941,442, According to a Recent SEC Filing

Argus Research

2 months ago

ANIP: Raising target price to $61.00

ANI Pharmaceuticals to Present at 36th Annual Piper Sandler Healthcare Conference

GlobeNewswire

2 months ago

ANI Pharmaceuticals to Present at 36th Annual Piper Sandler Healthcare Conference

Does ANI (ANIP) Have the Potential to Rally 31.31% as Wall Street Analysts Expect?

Zacks

2 months ago

Does ANI (ANIP) Have the Potential to Rally 31.31% as Wall Street Analysts Expect?

ANI (ANIP) Upgraded to Buy: What Does It Mean for the Stock?

Zacks

2 months ago

ANI (ANIP) Upgraded to Buy: What Does It Mean for the Stock?

Is Adagene (ADAG) Stock Outpacing Its Medical Peers This Year?

Zacks

2 months ago

Is Adagene (ADAG) Stock Outpacing Its Medical Peers This Year?

MT Newswires

2 months ago

Ani Pharmaceuticals Insider Sold Shares Worth $375,050, According to a Recent SEC Filing

Are Investors Undervaluing ANI Pharmaceuticals (ANIP) Right Now?

Zacks

2 months ago

Are Investors Undervaluing ANI Pharmaceuticals (ANIP) Right Now?

Argus Research

2 months ago

ANIP: Raising target price to $64.00

ANI Pharmaceuticals Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.

2 months ago

ANI Pharmaceuticals Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

GuruFocus.com

2 months ago

ANI Pharmaceuticals Inc (ANIP) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ...

Compared to Estimates, ANI (ANIP) Q3 Earnings: A Look at Key Metrics

Zacks

2 months ago

Compared to Estimates, ANI (ANIP) Q3 Earnings: A Look at Key Metrics

ANI Pharmaceuticals (ANIP) Q3 Earnings and Revenues Surpass Estimates

Zacks

2 months ago

ANI Pharmaceuticals (ANIP) Q3 Earnings and Revenues Surpass Estimates

MT Newswires

2 months ago

ANI Pharmaceuticals' Q3 Adjusted Earnings, Net Revenue Rise; Fiscal 2024 Outlook Lifted

Associated Press Finance

2 months ago

ANI: Q3 Earnings Snapshot

ANI Pharmaceuticals Reports Record Third Quarter 2024 Financial Results and Raises 2024 Guidance

GlobeNewswire

2 months ago

ANI Pharmaceuticals Reports Record Third Quarter 2024 Financial Results and Raises 2024 Guidance

ANI Pharmaceuticals Inc (ANIP) Q3 2024 Earnings Report Preview: What To Expect

GuruFocus.com

2 months ago

ANI Pharmaceuticals Inc (ANIP) Q3 2024 Earnings Report Preview: What To Expect

Argus Research

2 months ago

ANIP: Lowering target price to $60.00

ANI Pharmaceuticals to Present at Guggenheim's Inaugural Healthcare Innovation Conference and Jefferies London Healthcare Conference in November

GlobeNewswire

2 months ago

ANI Pharmaceuticals to Present at Guggenheim's Inaugural Healthcare Innovation Conference and Jefferies London Healthcare Conference in November

Earnings Preview: ANI Pharmaceuticals (ANIP) Q3 Earnings Expected to Decline

Zacks

3 months ago

Earnings Preview: ANI Pharmaceuticals (ANIP) Q3 Earnings Expected to Decline

ANI Pharmaceuticals to Discuss Third Quarter 2024 Financial Results on November 8, 2024, at 8:00 a.m. ET

GlobeNewswire

3 months ago

ANI Pharmaceuticals to Discuss Third Quarter 2024 Financial Results on November 8, 2024, at 8:00 a.m. ET

MT Newswires

3 months ago

ANI Pharmaceuticals Launches Estradiol Gel Following US FDA's Final Approval for Abbreviated New Drug Application

ANI Pharmaceuticals Announces the FDA Approval and Launch of Estradiol Gel, 0.06%

GlobeNewswire

3 months ago

ANI Pharmaceuticals Announces the FDA Approval and Launch of Estradiol Gel, 0.06%

ANI Pharmaceuticals to Present New Data Highlighting Membranous Nephropathy Research at American Society of Nephrology Kidney Week 2024

GlobeNewswire

3 months ago

ANI Pharmaceuticals to Present New Data Highlighting Membranous Nephropathy Research at American Society of Nephrology Kidney Week 2024

ANI Pharmaceuticals price target raised to $62 from $60 at Truist

TipRanks

3 months ago

ANI Pharmaceuticals price target raised to $62 from $60 at Truist

MT Newswires

3 months ago

Truist Raises Price Target on ANI Pharmaceuticals to $62 From $60, Keeps Hold Rating

Should Value Investors Buy ANI Pharmaceuticals (ANIP) Stock?

Zacks

3 months ago

Should Value Investors Buy ANI Pharmaceuticals (ANIP) Stock?

Are Medical Stocks Lagging Alnylam Pharmaceuticals (ALNY) This Year?

Zacks

3 months ago

Are Medical Stocks Lagging Alnylam Pharmaceuticals (ALNY) This Year?

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

Zacks

3 months ago

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

ANI Pharmaceuticals, Inc.'s (NASDAQ:ANIP) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?

Simply Wall St.

3 months ago

ANI Pharmaceuticals, Inc.'s (NASDAQ:ANIP) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

Zacks

3 months ago

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

Will ANI (ANIP) Beat Estimates Again in Its Next Earnings Report?

Zacks

3 months ago

Will ANI (ANIP) Beat Estimates Again in Its Next Earnings Report?

RPTX Stock Up as Dosing Begins in Solid Tumor Study for Combo Drug

Zacks

3 months ago

RPTX Stock Up as Dosing Begins in Solid Tumor Study for Combo Drug

Benzinga

3 months ago

ANI Pharmaceuticals Shifts Focus From Generics To High-Margin Brand Assets, Analyst Sees Strong Potential

MT Newswires

3 months ago

Piper Sandler Initiates Coverage on ANI Pharmaceuticals With Overweight Rating, $68 Price Target

Wall Street Analysts Predict a 42.98% Upside in ANI (ANIP): Here's What You Should Know

Zacks

3 months ago

Wall Street Analysts Predict a 42.98% Upside in ANI (ANIP): Here's What You Should Know

Argus Research

3 months ago

ANIP: Lowering target price to $60.00

Are Investors Undervaluing ANI Pharmaceuticals (ANIP) Right Now?

Zacks

4 months ago

Are Investors Undervaluing ANI Pharmaceuticals (ANIP) Right Now?

MT Newswires

4 months ago

Sector Update: Health Care Stocks Edge Higher Premarket Thursday

MT Newswires

4 months ago

ANI Pharmaceuticals Says FDA Approved Generic Version of Nizoral Anti-Dandruff Shampoo

ANI Pharmaceuticals Announces the FDA Approval and Launch of Ketoconazole Shampoo, 2%

GlobeNewswire

4 months ago

ANI Pharmaceuticals Announces the FDA Approval and Launch of Ketoconazole Shampoo, 2%

MT Newswires

4 months ago

ANI Pharmaceuticals Completes Purchase of Alimera Sciences, Sees 'Substantially Higher' Earnings After Deal

ANI Pharmaceuticals, Inc. Completes Acquisition of Alimera Sciences

GlobeNewswire

4 months ago

ANI Pharmaceuticals, Inc. Completes Acquisition of Alimera Sciences

ANI Pharmaceuticals Initiates Closing of Acquisition of Alimera Sciences

GlobeNewswire

4 months ago

ANI Pharmaceuticals Initiates Closing of Acquisition of Alimera Sciences

MT Newswires

4 months ago

ANI Pharmaceuticals Launches Oral Solution of Promethazine Hydrochloride and Dextromethorphan Hydrobromide

ANI Pharmaceuticals Launches Promethazine Hydrochloride and Dextromethorphan Hydrobromide Oral Solution

GlobeNewswire

4 months ago

ANI Pharmaceuticals Launches Promethazine Hydrochloride and Dextromethorphan Hydrobromide Oral Solution

Alimera Sciences (ALIM) Soars 6.6%: Is Further Upside Left in the Stock?

Zacks

4 months ago

Alimera Sciences (ALIM) Soars 6.6%: Is Further Upside Left in the Stock?

MT Newswires

4 months ago

ANI Pharmaceuticals, Alimera Sciences to Close Merger Next Week

Business Wire

4 months ago

ANI Pharmaceuticals and Alimera Sciences Announce Closing Date of Merger

MT Newswires

4 months ago

Alimera Sciences Sues ANI Pharmaceuticals for Delays in Merger Close

ANI Pharmaceuticals Provides Update on Closing of Acquisition of Alimera Sciences

GlobeNewswire

4 months ago

ANI Pharmaceuticals Provides Update on Closing of Acquisition of Alimera Sciences

ANI Pharmaceuticals, Inc. (ANIP): A Cheap Pharmaceutical Stock to Buy According to Short Sellers

Insider Monkey

5 months ago

ANI Pharmaceuticals, Inc. (ANIP): A Cheap Pharmaceutical Stock to Buy According to Short Sellers

Argus Research

5 months ago

ANIP: Raising target price to $66.00

Argus Research

5 months ago

ANIP: Raising target price to $64.00

Are Medical Stocks Lagging Argenx (ARGX) This Year?

Zacks

5 months ago

Are Medical Stocks Lagging Argenx (ARGX) This Year?

Should Value Investors Buy ANI Pharmaceuticals (ANIP) Stock?

Zacks

5 months ago

Should Value Investors Buy ANI Pharmaceuticals (ANIP) Stock?

ANI Pharmaceuticals' (NASDAQ:ANIP) Earnings Are Of Questionable Quality

Simply Wall St.

5 months ago

ANI Pharmaceuticals' (NASDAQ:ANIP) Earnings Are Of Questionable Quality

MT Newswires

5 months ago

ANI Pharmaceuticals Raises $316.25 Million From Convertible Senior Notes Offering

ANI Pharmaceuticals, Inc. Closes $316.25 Million Convertible Senior Notes Offering Including Full Exercise of Initial Purchasers’ Option to Purchase Additional Notes

GlobeNewswire

5 months ago

ANI Pharmaceuticals, Inc. Closes $316.25 Million Convertible Senior Notes Offering Including Full Exercise of Initial Purchasers’ Option to Purchase Additional Notes

ANI Pharmaceuticals Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.

5 months ago

ANI Pharmaceuticals Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

MT Newswires

5 months ago

ANI Pharmaceuticals Prices Upsized $275 Million Senior Notes Offering

ANI Pharmaceuticals, Inc. Prices Upsized $275.0 Million Convertible Senior Notes Offering

GlobeNewswire

5 months ago

ANI Pharmaceuticals, Inc. Prices Upsized $275.0 Million Convertible Senior Notes Offering

MT Newswires

5 months ago

ANI Pharmaceuticals Plans Convertible Senior Notes Offering

ANI Pharmaceuticals, Inc. Announces Proposed Convertible Senior Notes Offering

GlobeNewswire

5 months ago

ANI Pharmaceuticals, Inc. Announces Proposed Convertible Senior Notes Offering

MT Newswires

5 months ago

Sector Update: Health Care Stocks Rise Late Afternoon

MT Newswires

5 months ago

Sector Update: Health Care Stocks Rise in Afternoon Trading

MT Newswires

5 months ago

ANI Pharmaceuticals Shares Rise After Q2 Beat; Full Year 2024 Guidance Lifted

Compared to Estimates, ANI (ANIP) Q2 Earnings: A Look at Key Metrics

Zacks

5 months ago

Compared to Estimates, ANI (ANIP) Q2 Earnings: A Look at Key Metrics

ANI Pharmaceuticals (ANIP) Tops Q2 Earnings and Revenue Estimates

Zacks

5 months ago

ANI Pharmaceuticals (ANIP) Tops Q2 Earnings and Revenue Estimates

Associated Press Finance

5 months ago

ANI: Q2 Earnings Snapshot

ANI Pharmaceuticals Reports Second Quarter 2024 Financial Results and Raises 2024 Guidance

GlobeNewswire

5 months ago

ANI Pharmaceuticals Reports Second Quarter 2024 Financial Results and Raises 2024 Guidance

Seeking Clues to ANI (ANIP) Q2 Earnings? A Peek Into Wall Street Projections for Key Metrics

Zacks

5 months ago

Seeking Clues to ANI (ANIP) Q2 Earnings? A Peek Into Wall Street Projections for Key Metrics

ANI Pharmaceuticals to Discuss Second Quarter 2024 Financial Results on August 6, 2024, at 8:30 a.m. ET

GlobeNewswire

6 months ago

ANI Pharmaceuticals to Discuss Second Quarter 2024 Financial Results on August 6, 2024, at 8:30 a.m. ET

Argus Research

6 months ago

ANIP: Raising target price to $68.00

Syros (SYRS) Stock Rises More Than 35% in 3 Months: Here's Why

Zacks

6 months ago

Syros (SYRS) Stock Rises More Than 35% in 3 Months: Here's Why

Argus Research

6 months ago

ANIP: Raising target price to $67.00

MT Newswires

6 months ago

ANI Pharmaceuticals Launches L-Glutamine Oral Powder Following FDA Approval

ANI Pharmaceuticals Announces the FDA Approval and Launch of L-Glutamine Oral Powder

GlobeNewswire

6 months ago

ANI Pharmaceuticals Announces the FDA Approval and Launch of L-Glutamine Oral Powder

Argus Research

6 months ago

ANIP: Lowering target price to $64.00

MT Newswires

7 months ago

ANI Pharmaceuticals Receives FDA Approval for Naproxen Delayed-Release Tablets

Share on Social Networks: